We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
AUM
$3.71B
AUM Growth
+$963M
Cap. Flow
+$908M
Cap. Flow %
24.49%
Top 10 Hldgs %
38.05%
Holding
132
New
49
Increased
24
Reduced
12
Closed
44

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$105M
2
AMZN icon
Amazon
AMZN
+$62.3M
3
AVGO icon
Broadcom
AVGO
+$57.6M
4
TSN icon
Tyson Foods
TSN
+$56.8M
5
MDVN
MEDIVATION, INC.
MDVN
+$52M

Sector Composition

Rank Sector Weight
1 Healthcare 12.26%
2 Consumer Discretionary 9.59%
3 Technology 6.55%
4 Consumer Staples 5.53%
5 Communication Services 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
$49.8M 1.34%
+1,000,000
New +$52M
XLP icon
27
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$48.5M 1.31%
1,000,000
HRG
28
DELISTED
HRG Group, Inc.
HRG
$47.9M 1.29%
3,380,000
+780,000
+30% +$10.3M
RCPT
29
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$47.2M 1.27%
385,000
-32,000
-8% -$3.24M
AROC icon
30
Archrock
AROC
$6.27B
$46.8M 1.26%
1,435,000
+235,000
+20% +$8.39M
LEG icon
31
PUT
Leggett & Platt
LEG
$1.34B
$42.6M 1.15%
+1,000,000
New +$39.4M
BKD icon
32
Brookdale Senior Living
BKD
$3.49B
$42.2M 1.14%
1,150,000
+550,000
+92% +$18.6M
ENDP
33
DELISTED
Endo International plc
ENDP
$41.8M 1.13%
+580,000
New +$39.7M
DNOW icon
34
PUT
DNOW Inc
DNOW
$2.58B
$39.2M 1.06%
+1,524,800
New +$41.7M
BLUE
35
DELISTED
bluebird bio
BLUE
$38.6M 1.04%
+32,463
New +$21.7M
TGT icon
36
PUT
Target
TGT
$65.6B
$38M 1.02%
+500,000
New +$33.8M
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$11.6B
$37.5M 1.01%
415,000
-85,000
-17% -$7.07M
AMAT icon
38
Applied Materials
AMAT
$403B
$36.1M 0.97%
+1,450,000
New +$32.7M
WDC icon
39
Western Digital
WDC
$188B
$34M 0.92%
+406,161
New +$30.7M
AAPL icon
40
PUT
Apple
AAPL
$4.54T
$33.1M 0.89%
+1,200,000
New +$32.6M
GPRE icon
41
Green Plains
GPRE
$1.18B
$31M 0.84%
+1,250,581
New +$37.5M
AGU
42
PUT
DELISTED
Agrium
AGU
$28.4M 0.77%
+300,000
New +$28.1M
JD icon
43
PUT
JD.com
JD
$44.6B
$27.8M 0.75%
+1,200,000
New +$29.6M
NUS icon
44
PUT
Nu Skin
NUS
$252M
$26.2M 0.71%
+600,000
New +$26.5M
GPRE icon
45
CALL
Green Plains
GPRE
$1.18B
$25.5M 0.69%
+1,030,000
New +$30.9M
GPRE icon
46
PUT
Green Plains
GPRE
$1.18B
$24.8M 0.67%
+1,000,000
New +$30M
INSM icon
47
Insmed
INSM
$21.4B
$23.2M 0.63%
1,500,000
-26,343
-2% -$374K
STZ icon
48
Constellation Brands
STZ
$22.2B
$22.1M 0.6%
+225,000
New +$20.6M
SHLD
49
PUT
DELISTED
Sears Holding Corporation
SHLD
$21.4M 0.58%
650,000
+435,264
+203% +$14.3M
PPC icon
50
CALL
Pilgrim's Pride
PPC
$6.51B
$21.3M 0.58%
+650,000
New +$20.6M

Similar funds

Tourbillon Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Tourbillon Capital Partners held 132 positions worth $3.71B, up 35% from $2.74B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tourbillon Capital Partners deployed $908M of net new capital in Q4 2014, opening 49 new positions and adding to 24 existing holdings. Its largest new stake was Bausch Health: 780,000 shares worth $112M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $15M trimmed.

  • Tourbillon Capital Partners's largest Q4 2014 buy was Bausch Health: 780,000 shares worth $112M.
  • Tourbillon Capital Partners added most to Tyson Foods in Q4 2014, an estimated $56.8M increase.
  • Tourbillon Capital Partners's biggest Q4 2014 reduction was AMAG Pharmaceuticals, cutting an estimated $15M.
  • Tourbillon Capital Partners fully exited NXP Semiconductors in Q4 2014, selling an estimated $61.6M.
  • Tourbillon Capital Partners's ten largest holdings make up 38% of its $3.71B portfolio in Q4 2014.
  • Tourbillon Capital Partners opened 49 new positions and closed 44 in Q4 2014.
  • Tourbillon Capital Partners's portfolio value rose 35% quarter-over-quarter to $3.71B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.